Clive Peter Page

21PUBLICATIONS
51CO-AUTHORS
Molecular targetsAllergyMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 07, 2026
Identifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes.

|Mar 24, 2026
The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung.

Jennifer A Kricker, Yanira Riffo-Vasquez, Virginia Norris

|Nov 27, 2025
Synergistic Interactions Between the Quinolone-Derived Compound HT61 and Tobramycin Against a Range of Clinical Isolates of Pseudomonas aeruginosa In Vitro.

B Ramsden, A V Kelis, M-E Faure

|May 20, 2025
Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways.

Paola Rogliani, Clive Page, Francesco Facciolo

|May 06, 2025
Effect of Treatment with Mucoactive Drugs on COPD Exacerbations During 5 years of Follow-up in the Czech Republic: A Real-World Study.

Jaromír Zatloukal, Clive Page, Kristián Brat

|Mar 25, 2025
P2Y14 receptor activation of platelets induces Ca2+ mobilization and Rho-GTPase-dependent motility that requires an interaction with P2Y1 receptors.

Md Monir Hossain, Dingxin Pan, Kate L Arkless

Pageof 4

Frequent Collaborators

6 joint publications

Paola Rogliani

6 joint publications

Simon C Pitchford

6 joint publications

Mario Cazzola

5 joint publications

Luigino Calzetta